Switch to: References

Add citations

You must login to add citations.
  1. Beyond Pregnancy: A Public Health Case for a Technological Alternative.Andrea Bidoli & Ezio Di Nucci - 2023 - International Journal of Feminist Approaches to Bioethics 16 (1):103-130.
    This paper aims to problematize pregnancy and support the development of a safe alternative method of gestation. Our arguments engage with the health risks of gestation and childbirth, the value assigned to pregnancy, as well as social and medical attitudes toward women’s pain, especially in labor. We claim that the harm caused by pregnancy and childbirth provides a prima facie case in favor of prioritizing research on a method of extra corporeal gestation.
    Download  
     
    Export citation  
     
    Bookmark   2 citations  
  • (1 other version)Understanding and Correcting Sex Disparity in Cardiovascular Disease Research: Ethical and Practical Solutions.Lida Sarafraz - 2021 - International Journal of Feminist Approaches to Bioethics 14 (2):81-96.
    Cardiovascular disease is the leading cause of death of women in the United States, yet cardiovascular research is disproportionately conducted using male human subjects and male animal models. This article deploys Katrina Hutchison’s (2019) analysis of gender disparity in clinical trials as a moral aggregation problem to address the problem of underrepresentation of women in cardiovascular research. I identify cost concerns, convenience, pregnancy, and negligence as potential reasons for the underrepresentation of women in CVD research. Finally, I suggest that multilevel (...)
    Download  
     
    Export citation  
     
    Bookmark  
  • (1 other version)Donchin and Holmes Emerging Scholar Prize Paper Understanding and Correcting Sex Disparity in Cardiovascular Disease Research: Ethical and Practical Solutions.Lida Sarafraz - 2021 - International Journal of Feminist Approaches to Bioethics 14 (2):81-96.
    Cardiovascular disease is the leading cause of death of women in the United States, yet cardiovascular research is disproportionately conducted using male human subjects and male animal models. This article deploys Katrina Hutchison’s (2019) analysis of gender disparity in clinical trials as a moral aggregation problem to address the problem of underrepresentation of women in cardiovascular research. I identify cost concerns, convenience, pregnancy, and negligence as potential reasons for the underrepresentation of women in CVD research. Finally, I suggest that multilevel (...)
    Download  
     
    Export citation  
     
    Bookmark  
  • Ethical and Legal Considerations of Alternative Neurotherapies.Ashwini Nagappan, Louiza Kalokairinou & Anna Wexler - 2021 - American Journal of Bioethics Neuroscience 12 (4):257-269.
    Neurotherapies for diagnostics and treatment—such as electroencephalography (EEG) neurofeedback, single-photon emission computerized tomography (SPECT) imaging for neuropsychiatric evaluation, and off-label/experimental uses of brain stimulation—are continuously being offered to the public outside mainstream healthcare settings. Because these neurotherapies share many key features of complementary and alternative medicine (CAM) techniques—and meet the definition of CAM as set out in Kaptchuk and Eisenberg—here we refer to them as “alternative neurotherapies.” By explicitly linking these alternative neurotherapy practices under a common conceptual framework, this paper (...)
    Download  
     
    Export citation  
     
    Bookmark   5 citations  
  • Vaccine confidence, public understanding and probity: time for a shift in focus?Ana Wheelock & Jonathan Ives - 2022 - Journal of Medical Ethics 48 (4):250-255.
    Lack of vaccine confidence can contribute to drops in vaccination coverage and subsequent outbreaks of diseases like measles and polio. Low trust in vaccines is attributed to a combination of factors, including lack of understanding, vaccine scares, flawed policies, social media and mistrust of vaccine manufacturers, scientists and decision-makers. The COVID-19 crisis has laid bare societies’ vulnerability to new pathogens and the critical role of vaccines in containing this and future pandemics. It has also put science at the forefront of (...)
    Download  
     
    Export citation  
     
    Bookmark   1 citation  
  • What’s it to me? Self-interest and evaluations of financial conflicts of interest.Samuel V. Bruton & Donald F. Sacco - 2017 - Research Ethics 14 (4):1-17.
    Disclosure has become the preferred way of addressing the threat to researcher objectivity arising from financial conflicts of interest. This article argues that the effectiveness of disclosure at protecting science from the corrupting effects of FCOIs—particularly the kind of disclosure mandated by US federal granting agencies—is more limited than is generally acknowledged. Current NIH and NSF regulations require disclosed FCOIs to be reviewed, evaluated, and managed by officials at researchers’ home institutions. However, these reviewers are likely to have institutional and (...)
    Download  
     
    Export citation  
     
    Bookmark   1 citation  
  • Health Professionals “Make Their Choice”: Pharmaceutical Industry Leaders’ Understandings of Conflict of Interest.Quinn Grundy, Lisa Tierney, Christopher Mayes & Wendy Lipworth - 2017 - Journal of Bioethical Inquiry 14 (4):541-553.
    Conflicts of interest, stemming from relationships between health professionals and the pharmaceutical industry, remain a highly divisive and inflammatory issue in healthcare. Given that most jurisdictions rely on industry to self-regulate with respect to its interactions with health professionals, it is surprising that little research has explored industry leaders’ understandings of conflicts of interest. Drawing from in-depth interviews with ten pharmaceutical industry leaders based in Australia, we explore the normalized and structural management of conflicts of interest within pharmaceutical companies. We (...)
    Download  
     
    Export citation  
     
    Bookmark   1 citation